Yu Min

Academician

Institution
Chinese Academy of Sciences

Country
China

Field
Physics

Yu was given the 2014 National Highest Science and Technology Award, China’s top science award, for his research into hydrogen bombs.

(Photo: Peking University)


Related articles

Two Coronavirus Lineages But Similar Clinical Outcomes, Study Shows

A study has identified two lineages of SARS-CoV-2 stemming from one common ancestor in Wuhan city, both exhibiting similar virulence and clinical outcomes.

These Three Biomarkers May Predict COVID-19 Death Risk: Study

A machine learning model developed by Wuhan scientists predicted the death of COVID-19 patients ten days in advance of their outcomes with more than 90 percent accuracy.

CRISPR Helps Find Alzheimer’s-Linked Protein

Researchers have used a CRISPR-based genetic screen to identify a new gene that could regulate the development of Alzheimer’s disease.

Predicting The March Of COVID-19 From Mobile Phone Data

Using anonymized mobile phone data from nearly 11.5 million people, researchers could predict the spread of COVID-19 infections from Wuhan, China, up to two weeks in advance.

Wuhan Travel Ban Prevented 700,000 COVID-19 Cases: Report

Tough control measures taken by China in the first 50 days of the epidemic may have prevented more than 700,000 infections, a study finds.

A Fishy Solution To Sustainable Wearable Tech

Films derived from fish scales could represent a promising alternative for more sustainable flexible electronics, including wearables and folding displays.

Why Do Scorpions Glow Under UV Light?

Scientists in Japan have found that scorpions make a fluorescent compound to protect themselves from parasites.

The GDP Fudge: China Edition

By linking GDP growth to promotions, the Chinese government has inadvertently created incentives for provincial officials to report inaccurate financial data, a study says.

Advancing Antibody Research

Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki Igawa.